
|Slideshows|April 4, 2018
sTMS Device May Prevent Migraine
Author(s)Veronica Hackethal, MD
A study undertaken to evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine has led to an FDA extended indication.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MD
2
Mapping the Clinical Trial Landscape for Stem Cell Therapies in Parkinson Disease
3
What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson Disease
4
Fenebrutinib Demonstrates Strong Efficacy, Favorable Safety in FENhance MS Trials: Jacqueline Nicholas, MD
5














